A limiting dilution assay was developed to quantitate
urushiol (the
antigen of poison ivy; Toxicodendron radicans) specific T cells from peripheral blood of a patient with a history of rhus (
poison ivy) dermatitis. It was found that maximal sensitivity with minimal nonspecific proliferation could be produced with the use of 5 U/ml of recombinant
IL2 added to the assay on day 6. This donor was found to have a frequency of
urushiol specific peripheral blood T cells of (1/2935). Five
interleukin 2 (
IL2) dependent
urushiol specific T-cell clones were generated from the peripheral blood of this patient. These T-cell clones had a CD8+ (T8+) phenotype and proliferated specifically to both extracts of Toxicodendron radicans (poison ivy) leaves and pure
urushiol. Pentadecylcatechol was an inferior
antigen, only stimulating proliferation of one clone. The ability of all clones to proliferate to pure
urushiol, despite their having been induced with leaf extract, suggests that
urushiol, or closely related
catechols, represent the only allergenic constituents of Toxicodendron radicans. Lymphokine production in response to
antigen varied between (0.6-5.0) units/ml of
interleukin 2 (
IL2) and (1.0-120) units/ml of
gamma interferon. Although none of the clones showed significant cytotoxicity against NK targets, three of five lines showed considerable cytotoxicity against
concanavalin A treated (
lectin approximated) targets. However, cytotoxicity for rhus conjugated autologous targets was not detected. It was found that several of these CD8+ clones could suppress
IgG production in the presence of rhus
antigen. The isolation of these T-cells from peripheral blood several months after
rhus dermatitis suggests that these clones may have a role in down regulating
delayed hypersensitivity to
urushiol.